Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Rockwell Medical In (RMTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 447,716
  • Shares Outstanding, K 52,060
  • Annual Sales, $ 53,280 K
  • Annual Income, $ -19,800 K
  • 36-Month Beta 2.03
  • Price/Sales 8.42
  • Price/Cash Flow 0.00
  • Price/Book 8.39

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.92 +45.27%
on 03/31/17
8.97 -4.12%
on 04/27/17
+1.97 (+29.71%)
since 03/28/17
3-Month
5.27 +63.19%
on 01/30/17
8.97 -4.12%
on 04/27/17
+2.99 (+53.30%)
since 01/27/17
52-Week
3.55 +142.25%
on 11/08/16
10.58 -18.71%
on 06/03/16
-1.16 (-11.89%)
since 04/28/16

Most Recent Stories

More News
Uptrend Call Working As Rockwell Medical Technologies Stock Rises 19.6% (RMTI)

SmarTrend identified an Uptrend for Rockwell Medical Technologies (NASDAQ:RMTI) on March 28th, 2017 at $6.56. In approximately 3 weeks, Rockwell Medical Technologies has returned 19.60% as of today's...

RMTI : 8.60 (-0.23%)
Richmond Brothers and Mark H. Ravich Send Letter to Rockwell Medical, Inc. Shareholders

--Highlight Series of Strategic Missteps and Failures to Execute, Including Inability to Monetize Promising Drugs Triferic and Calcitriol

RMTI : 8.60 (-0.23%)
TIS : 24.35 (-4.55%)
Rockwell Medical (RMTI) Catches Eye: Stock Moves Up 12.1%

Rockwell Medical, Inc. (RMTI) moved big last session, as its shares rose over 12% on the day.

ZLTQ : 56.48 (unch)
RMTI : 8.60 (-0.23%)
Rockwell Medical (RMTI) Looks Good: Stock Moves 5.9% Higher

Rockwell Medical, Inc. (RMTI) shares rose almost 6% in the last trading session.

RMTI : 8.60 (-0.23%)
CAPR : 3.12 (-1.27%)
Richmond Brothers and Mark Ravich File Preliminary Proxy on Rockwell Medical, Inc.

--Highlight Disastrous Historical Stock Price Performance and Note that RMTI's Share Price Is Down 52.5% over the Three Years Leading up to Richmond/Ravich Public Involvement

RMTI : 8.60 (-0.23%)
Rockwell Medical Files Preliminary Proxy Statement for Annual Meeting

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of...

RMTI : 8.60 (-0.23%)
Rockwell Medical Announces ESA Sparing, Compositions and Use Patent Allowed in China

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of...

RMTI : 8.60 (-0.23%)
Richmond Brothers and Mark Ravich Comment on Rockwell Medical, Inc. Lawsuit

--Believe Rockwell's Lawsuit is a Baseless Waste of Shareholder Money, and Nothing More than an Attempt to Distract Shareholders from Ongoing Underperformance and Failed Execution

RMTI : 8.60 (-0.23%)
Richmond Brothers and Mark Ravich Comment on Rockwell Medical, Inc. Earnings

--Dismayed that Shareholders Were Denied Opportunity to Ask Questions on Earnings Call - Reinforcing Need for Increased Transparency with Investors

RMTI : 8.60 (-0.23%)
Rockwell Medical Reports Fourth Quarter Results

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the...

RMTI : 8.60 (-0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able...

See More

Support & Resistance

2nd Resistance Point 8.94
1st Resistance Point 8.77
Last Price 8.60
1st Support Level 8.50
2nd Support Level 8.40

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.